Authors
Astoyan L.Т., Izmailova S.B., Maychuk D.Y., Taevere M.R.
The S. Fyodorov Eye Microsurgery Federal State Institution, Moscow
Abstract
Rationale: Corneal crosslinking (CXL) is a modern method of treatment used for different origin keratectasia and corneal inflammatory diseases.
Objective: of the study was to evaluate the possibilities of modified CXL using silver nanoparticles in non-standard cases of corneal pathology.
Methods: The study analysed the clinical and functional results of 6 patients (6 eyes) with corneal inflammatory diseases. All patients underwent CXL using silver nanoparticles.
Results: All patients showed stabilization of the inflammatory process.
Conclusion: The experience of using modified CXL with silver nanoparticles suggests that procedure is effective as part of complex treatment of corneal inflammatory pathology, which is guarantee of success for the use of more radical treatment methods.
Keywords: UV crosslinking, corneas, inflammation, corneal ulcer, keratitis, silver nanoparticles.
References
1. Kasparova E.A., Byao I., Sobkova O.I. Мodified cross-linking in the trеatment of advanced purulent corneal ulcer. Сlinical case. Ophthalmology in Russia. 2017;14(3):274-277. doi: 10. 18008/1816-5095-2017-3-274-277.
2. Khan N.A. Acanthamoeba: Biology and increasing importance in human health. FEMS Microbiol. Rev. 2006;30:564–595. doi: 10.1111/j.1574-6976.2006.00023.x.
3. Izmajlova S.B., Malyugin B.E., Sahnov S.N., Komarova O.YU., YArkin D.A., Malyshev I.S. Desyatiletnij opyt primeneniya original'nogo algoritma hirurgicheskogo lecheniya pacientov s nachal'nymi stadiyami keratokonusa. Oftal'mohirurgiya. 2021;3: 28–39.
4. Sharma G., Kalra S.K., Tejan N., Ghoshal U. Nanoparticles based therapeutic efficacy against 5.Acanthamoeba: Updates and future prospect. Exp. Parasitol. 2020;218:8008. doi: 10.1016/j.exppara.2020.108008. – DOI – PubMed Hou Y, Le VNH, Toth G, et al... UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high-risk corneal transplant survival. Am J Transplant. 2018; 18: 2873–2884.
6. Kasparova E.A. Modern treatment of the purulent corneal ulcers. Annals of Ophthalmology=Vestnik Oftalmologii. 2016;5:125 135. doi:10.17116/oftalma20161325125 135 (in Russ.)
7. Sugita A., Okada Y., Uchara K. Photosensitized inactivation of ribonucleic acids in the presence of riboflavin. Biochim Biophys Acta. 1965;103: 360–363.
8. Said D., Elalfy M., Gatzioufas Z. Collagen Cross Linking with Photoactivated Riboflavin (PACK CXL) for the Treatment of Advanced Infectious Keratitis with Corneal Melting. Ophthalmology. 2014:121(7):1377 82. doi: 10.1016/j. ophtha.2014.01.01
